Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Keheng shares: signed a cooperation framework agreement with Gree supply chain, and Keheng shares announced that the company and its wholly-owned subsidiaries Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology signed a cooperation framework agreement with Gree supply chain. Gree supply chain granted Jiangmen Keheng, Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology a total of 650 million yuan in raw material procurement business.US official-designate: The House panel will consider relaxing supervision and cryptocurrency structure. On Friday, Congressman Francci Hill, who will be the incoming chairman of the US House Financial Services Committee, said that the committee will focus on relaxing bank supervision, solving the problem of capital formation, so that more companies can go public, and solving the market structure of cryptocurrency. Hill also said in an interview that he has not yet decided whether the United States should establish a bitcoin reserve.
Sources: Russia has suspended grain exports to Syria. Russian and Syrian sources said on Friday that Russia's wheat supply to Syria has been suspended due to the uncertainty of the new Syrian government and the delay in payment.Russia's seaborne grain exports in November increased by 39.5% to 4.8 million tons.Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.
Sources: Russia has suspended grain exports to Syria. Russian and Syrian sources said on Friday that Russia's wheat supply to Syria has been suspended due to the uncertainty of the new Syrian government and the delay in payment.Yunnan Nengtou: It is planned to invest in Yongning wind farm expansion project. Yunnan Nengtou announced that Maitreya Company, a wholly-owned subsidiary, plans to invest in Yongning wind farm expansion project (Maitreya area), with a total installed capacity of 230,000 kilowatts and a total investment of 1.323 billion yuan (including 6.9 million yuan in working capital). On the same day, it was announced that Honghe Company, a wholly-owned subsidiary, planned to invest in the Yongning Wind Farm Expansion Project (Luxi Area), with a total installed capacity of 235,000 kilowatts and a total investment of 1.395 billion yuan (including 7.05 million yuan in working capital).The US import price index in November was 1.3% year-on-year, expected to be 1%, and the previous value was 0.8%. The annual export price index of the United States in November was 0.8%, expected to be 0.3%, and the previous value was-0.10%.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14